TGFβ/Smad4-dependent and -independent regulation of human lens epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 11, 2009, Pages 5318-5327

  Dawes, Lucy Jean ^a   Sleeman, Matthew Alexander ^b   Anderson, Ian Keith ^b   Reddan, John R ^c   Wormstone, Ian Michael ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b MEDIMMUNE   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; ACTIN; ALPHA SMA PROTEIN, HUMAN; ALPHA-SMA PROTEIN, HUMAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD4 PROTEIN, HUMAN;

ARTICLE; CELL STRAIN; CELL TRANSDIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LENS EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL LINE; CELL NUCLEUS; DRUG EFFECT; GENE SILENCING; GENETICS; IMMUNOHISTOCHEMISTRY; LENS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CELL TRANSDIFFERENTIATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LENS, CRYSTALLINE; MAP KINASE KINASE 4; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 77951244050     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3223     Document Type: Article

References (52)

1. Wormstone IM. Posterior capsule opacification: a cell biological perspective. Exp Eye Res. 2002;74:337-347.
2. Saika S, Miyamoto T, Ishida I, et al. TGFβ-Smad signalling in postoperative human lens epithelial cells. Br J Ophthalmol. 2002; 86:1428-1433.
3. Saika S, Miyamoto T, Kawashima Y, et al. Immunolocalization of TGF-beta1, -beta2, and -beta3, and TGF-beta receptors in human lens capsules with lens implants. Graefes Arch Clin Exp Ophthalmol. 2000;238:283-293.
4. Ohta K, Yamagami S, Taylor AW, Streilein JW. IL-6 antagonizes TGF-β and abolishes immune privilege in eyes with endotoxininduced uveitis. Invest Ophthalmol Vis Sci. 2000;41:2591-2599.
5. Schlotzer-Schrehardt U, Zenkel M, Kuchle M, Sakai LY, Naumann GOH. Role of transforming growth factor-beta 1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
6. Dawes LJ, Eldred JA, Anderson IK, et al. TGFβ-induced contraction is not promoted by fibronectin-fibronectin receptor interaction, or αSMA Expression. Invest Ophthalmol Vis Sci. 2008;49:650-661.
7. Gordon-Thomson C, de Iongh R, Hales A, Chamberlain C, McAvoy J. Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and their expression in the postnatal rat eye. Invest Ophthalmol Vis Sci. 1998;39:1399-1409.
8. Kurosaka D, Kato K, Nagamoto T, Negishi K. Growth factors influence contractility and alpha-smooth muscle actin expression in bovine lens epithelial cells. Invest Ophthalmol Vis Sci. 1995; 36:1701-1708.
9. Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-β2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci. 2002;43:2301-2308.
10. Wormstone IM, Tamiya S, Eldred JA, et al. Characterisation of TGF-beta2 signalling and function in a human lens cell line. Exp Eye Res. 2004;78:705-714.
11. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994;124:401-404.
12. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
13. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J. 2004;18:816-827.
14. Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753-791.
15. Feng XH, Derynck R. Specificity and versatility in TGF-beta signaling through Smads. Ann Rev Cell Dev Biol. 2005;21:659-693.
16. Daly AC, Randall RA, Hill CS. Transforming growth factor β-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol. 2008;28:6889-6902.
17. von Gersdorff G, Susztak K, Rezvani F, et al. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem. 2000;275: 11320-11326.
18. Flanders K. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol. 2004;85:47-64.
19. Derynck R, Zhang Y. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577-584.
20. Levy L, Hill CS. Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-β -induced epithelial-mesenchymal transition from its antipro- liferative and migratory responses. Mol Cell Biol. 2005;25:8108-8125.
21. Chu GC, Dunn NR, Anderson DC, Oxburgh L, Robertson EJ. Differential requirements for Smad4 in TGFβ-dependent patterning of the early mouse embryo. Development. 2004;131:3501-3512.
22. Wisotzkey RG, Mehra A, Sutherland DJ, et al. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development. 1998;125:1433-1445.
23. Kopp J, Preis E, Said H, et al. Abrogation of transforming growth factor-β signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem. 2005;280:21570-21576.
24. Deckers M, van Dinther M, Buijs J, et al. The tumor suppressor Smad4 Is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 2006;66:2202-2209.
25. Sirard C, Kim S, Mirtsos C, et al. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling. J Biol Chem. 2000;275:2063-2070.
26. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4- independent pathway. EMBO J. 1999;18:1345-1356.
27. Hales AM, Chamberlain CG, McAvoy JW. Cataract induction in lenses cultured with transforming growth factor- beta. Invest Ophthalmol Vis Sci. 1995;36:1709-1713.
28. Lee EH and Joo C-K. Role of transforming growth factor-β in transdifferentiation and fibrosis of lens epithelial cells. Invest Ophthalmol Vis Sci. 1999;40:2025-2032.
29. Banh A, Deschamps PA, Gauldie J, et al. Lens-specific expression of TGF-β induces anterior subcapsular cataract formation in the absence of Smad3. Invest Ophthalmol Vis Sci. 2006;47:3450-3460.
30. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol. 2004;164:651-663.
31. Spirin KS, Saghizadeh M, Lewin SL, et al. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr Eye Res. 1999;18:490-499.
32. Kitamura K, Aota S-i, Sakamoto R, Yoshikawa S-I and Okazaki K. Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation. Blood. 2000;95:3371-3379.
33. Knott RM, Muckersie E, Robertson M, Forrester JV. Glucose-dependent regulation of DNA synthesis in bovine retinal endothelial cells. Curr Eye Res. 1998;17:1-8.
34. Hosler MR, Wang-Su S-T and Wagner BJ. Role of the proteasome in TGF-β signaling in lens epithelial cells. Invest Ophthalmol Vis Sci. 2006;47:2045-2052.
35. Saika S, Ikeda K, Yamanaka O, et al. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Investig. 2004;84:1259-1270.
36. Masszi A, Di Ciano C, Sirokmany G, et al. Central role for Rho in TGF-beta 1-induced alpha -smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol. 2003;284:F911-F924.
37. Nakao A, Okumura K, Ogawa H. Smad7: a new key player in TGF-beta-associated disease. Trends Mol Med. 2002;8:361-363.
38. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999;397:710-713.
39. Garrett Q, Khaw PT, Blalock TD, et al. Involvement of CTGF in TGF-β1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci. 2004;45:1109-1116.
40. Sirard C, de la Pompa JL, Elia A, et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 1998;12:107-119.
41. Fink SP, Mikkola D, Willson JK, Markowitz S. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Oncogene. 2003;22:1317-1323.
42. He W, Dorn DC, Erdjument-Bromage H, et al. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell. 2006;125:929-941.
43. Descargues P, Sil AK, Sano Y, et al. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci USA. 2008;105:2487-2492.
44. Xu L, Kang Y, Col S, Massague J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol Cell. 2002; 10:271-282.
45. Xiao Z, Liu X, Lodish HF. Importin beta mediates nuclear translocation of Smad 3. J Biol Chem. 2000;275:23425-23428.
46. Shi Y, Wang YF, Jayaraman L, et al. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell. 1998;94:585-594.
47. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005;19:2783-2810.
48. Parizi M, Howard EW, Tomasek JJ. Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res. 2000;254:210-220.
49. Klemke RL, Cai S, Giannini AL, et al. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol. 1997;137:481-492.
50. Borbiev T, Birukova A, Liu F, et al. p38 MAP kinase-dependent regulation of endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol. 2004;287:L911-L918.
51. Petrich BG, Wang Y. Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med. 2004;14:50-55.
52. Dawes LJ, Elliott RM, Reddan JR, Wormstone YM, Wormstone IM. Oligonucleotide microarray analysis of human lens epithelial cells: TGF beta regulated gene expression. Mol Vis. 2007;13:1181-1197.